750 related articles for article (PubMed ID: 17171187)
1. Citicoline: pharmacological and clinical review, 2006 update.
Secades JJ; Lorenzo JL
Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
[TBL] [Abstract][Full Text] [Related]
2. CDP-choline: pharmacological and clinical review.
Secades JJ; Frontera G
Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
Conant R; Schauss AG
Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642
[TBL] [Abstract][Full Text] [Related]
4. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
[TBL] [Abstract][Full Text] [Related]
5. Greatly improved neuroprotective efficiency of citicoline by stereotactic delivery in treatment of ischemic injury.
Xu F; Hongbin Han ; Yan J; Chen H; He Q; Xu W; Zhu N; Zhang H; Zhou F; Lee K
Drug Deliv; 2011; 18(7):461-7. PubMed ID: 21923252
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of mild cognitive impairment: value of citicoline].
Abad-Santos F; Novalbos-Reina J; Gallego-Sandín S; García AG
Rev Neurol; 2002 Oct 1-15; 35(7):675-82. PubMed ID: 12389156
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
[TBL] [Abstract][Full Text] [Related]
8. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
Parnetti L; Mignini F; Tomassoni D; Traini E; Amenta F
J Neurol Sci; 2007 Jun; 257(1-2):264-9. PubMed ID: 17331541
[TBL] [Abstract][Full Text] [Related]
9. Citicoline, use in cognitive decline: vascular and degenerative.
García-Cobos R; Frank-García A; Gutiérrez-Fernández M; Díez-Tejedor E
J Neurol Sci; 2010 Dec; 299(1-2):188-92. PubMed ID: 20875651
[TBL] [Abstract][Full Text] [Related]
10. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives.
Gareri P; Castagna A; Cotroneo AM; Putignano S; De Sarro G; Bruni AC
Clin Interv Aging; 2015; 10():1421-9. PubMed ID: 26366063
[TBL] [Abstract][Full Text] [Related]
11. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair.
Saver JL
Rev Neurol Dis; 2008; 5(4):167-77. PubMed ID: 19122569
[TBL] [Abstract][Full Text] [Related]
12. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
Fioravanti M; Yanagi M
Cochrane Database Syst Rev; 2005 Apr; (2):CD000269. PubMed ID: 15846601
[TBL] [Abstract][Full Text] [Related]
13. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E
J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595
[TBL] [Abstract][Full Text] [Related]
14. [The current state of citicholine in cerebral ischemia].
Abad-Santos F; Gallego-Sandín S; Novalbos J; Gálvez-Múgica MA
Rev Neurol; 2000 Apr 1-15; 30(7):663-70. PubMed ID: 10859748
[TBL] [Abstract][Full Text] [Related]
15. Citicoline improves memory performance in elderly subjects.
Alvarez XA; Laredo M; Corzo D; Fernández-Novoa L; Mouzo R; Perea JE; Daniele D; Cacabelos R
Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):201-10. PubMed ID: 9203170
[TBL] [Abstract][Full Text] [Related]
16. Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study.
Babb SM; Wald LL; Cohen BM; Villafuerte RA; Gruber SA; Yurgelun-Todd DA; Renshaw PF
Psychopharmacology (Berl); 2002 May; 161(3):248-54. PubMed ID: 12021827
[TBL] [Abstract][Full Text] [Related]
17. Citicoline: pharmacological and clinical review, 2010 update.
Secades JJ
Rev Neurol; 2011 Mar; 52 Suppl 2():S1-S62. PubMed ID: 21432836
[TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence.
Brown ES; Gorman AR; Hynan LS
J Clin Psychopharmacol; 2007 Oct; 27(5):498-502. PubMed ID: 17873684
[TBL] [Abstract][Full Text] [Related]
19. [Neuroprotection in acute ischemic stroke. Practicability of guidelines for treatment].
Fridman EA; Ottaviano F; Fiol M; Javelier A; Perea JE; Ameriso SF
Rev Neurol; 2001 May 1-15; 32(9):818-21. PubMed ID: 11424030
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of oral citicoline in acute ischemic stroke: drug surveillance study in 4,191 cases.
Cho HJ; Kim YJ
Methods Find Exp Clin Pharmacol; 2009 Apr; 31(3):171-6. PubMed ID: 19536360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
